Myriad Genetics Inc (NASDAQ:MYGN)

34.07
Delayed Data
As of Feb 27
 -0.89 / -2.55%
Today’s Change
31.56
Today|||52-Week Range
42.50
+0.03%
Year-to-Date

Today’s Trading

Previous close34.96
Today’s open34.80
Day’s range33.66 - 35.26
Volume713,820
Average volume (3 months)923,781
Market cap$2.4B
Dividend yield--
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)+27.12%
Earnings growth (this year)-37.29%
Earnings growth (next 5 years)+13.75%
Revenue growth (last year)+26.92%
P/E ratio23.7
Price/Sales3.31
Price/Book3.48

Competitors

 Today’s
change
Today’s
% change
HZNPHorizon Pharma PLC+1.46+7.66%
PTCTPTC Therapeutics Inc-2.13-2.90%
--Cosmo Pharmaceutical...+9.35+6.24%
CLVSClovis Oncology Inc-1.43-1.84%
Data as of 3:59pm ET, 02/27/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)$0.39
Annual revenue (last year)$778.2M
Annual profit (last year)$176.2M
Net profit margin22.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Peter D. Meldrum
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account